Indeed, the stem cell phenotype induced by FBXO11 depletion is sufficient to cooperate with AML1-ETO and KRASG12D to produce a synthetic serially transplantable leukemia from normal CD34+ cells. This evidence concerns the gene FBXO11 and leukemia.